The decision gives certain patients whose cancer has resisted BCG therapy another treatment option aimed at preserving the ...

Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...

American Society for Radiation Oncology (ASTRO) published its first clinical practice guideline on radiation therapy for ...

ImmunityBio (IBRX) stock rises as FDA expands ANKTIVA approval to papillary-only bladder cancer, widening treatment access ...

The U.S. Food and Drug Administration (FDA) has approved a new combination treatment of pembrolizumab (brand name: Keytruda) combined with enfortumab vedotin‑ejfv (brand name: Padcev) for people with ...

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following ...

Thirteen years ago, Jill Hamilton-Reeves was a board-certified oncology nutritionist at the University of Kansas Medical Center when Jeffrey Holzbeierlein, a urologist, told her about a patient he was ...

Newswise — PHOENIX — A Mayo Clinic-led international phase 3 study found that a new immunotherapy helped many patients with an aggressive form of bladder cancer keep their bladder instead of having it ...

Deion Sanders is embracing a new normal following his bladder removal surgery last month. The former NFL star was forced to bring a portable toilet to Folsom Field while joining the team he coaches, ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Virtuoso Surgical Inc., a Nashville-based surgical robotics company, today announced the first-in-human use of its Virtuoso system, ushering in a new era of ...

AstraZeneca has added another indication to its blockbuster immunotherapy Imfinzi (durvalumab), gaining European approval to treat a type of bladder cancer. Imfinzi is now approved to treat adult ...